Genomic technologies in cancer research, drug discovery and development

Kwai Wa Cheng, Janos L. Tanyi, Gordon Mills

Research output: Contribution to journalArticle

Abstract

The human genome project has provided a wealth of new information about the sequences of individual genes and their location on chromosomes. The completion of human genome project has the potential to revolutionize progress in advancing medical science. There is major interest in linking the human genome project to changes in gene and protein expression and function because such variations might be directly related to the development and/or progression of multiple human diseases. Indeed, the completion of the human genome project has already accelerated the identification of disease associated genetic aberrations.

Original languageEnglish (US)
Pages (from-to)16-24
Number of pages9
JournalCME Journal of Gynecologic Oncology
Volume7
Issue number1
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Human Genome Project
Drug Discovery
Technology
Research
Neoplasms
Inborn Genetic Diseases
Chromosomes
Gene Expression
Genes
Proteins

Keywords

  • Cancer
  • Drug development
  • Gene technology
  • Genes
  • Genetic alterations

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Genomic technologies in cancer research, drug discovery and development. / Cheng, Kwai Wa; Tanyi, Janos L.; Mills, Gordon.

In: CME Journal of Gynecologic Oncology, Vol. 7, No. 1, 01.01.2002, p. 16-24.

Research output: Contribution to journalArticle

@article{4807007ff76a411ea57ab34247426be8,
title = "Genomic technologies in cancer research, drug discovery and development",
abstract = "The human genome project has provided a wealth of new information about the sequences of individual genes and their location on chromosomes. The completion of human genome project has the potential to revolutionize progress in advancing medical science. There is major interest in linking the human genome project to changes in gene and protein expression and function because such variations might be directly related to the development and/or progression of multiple human diseases. Indeed, the completion of the human genome project has already accelerated the identification of disease associated genetic aberrations.",
keywords = "Cancer, Drug development, Gene technology, Genes, Genetic alterations",
author = "Cheng, {Kwai Wa} and Tanyi, {Janos L.} and Gordon Mills",
year = "2002",
month = "1",
day = "1",
language = "English (US)",
volume = "7",
pages = "16--24",
journal = "CME Journal of Gynecologic Oncology",
issn = "1219-9087",
publisher = "Primed-X Press",
number = "1",

}

TY - JOUR

T1 - Genomic technologies in cancer research, drug discovery and development

AU - Cheng, Kwai Wa

AU - Tanyi, Janos L.

AU - Mills, Gordon

PY - 2002/1/1

Y1 - 2002/1/1

N2 - The human genome project has provided a wealth of new information about the sequences of individual genes and their location on chromosomes. The completion of human genome project has the potential to revolutionize progress in advancing medical science. There is major interest in linking the human genome project to changes in gene and protein expression and function because such variations might be directly related to the development and/or progression of multiple human diseases. Indeed, the completion of the human genome project has already accelerated the identification of disease associated genetic aberrations.

AB - The human genome project has provided a wealth of new information about the sequences of individual genes and their location on chromosomes. The completion of human genome project has the potential to revolutionize progress in advancing medical science. There is major interest in linking the human genome project to changes in gene and protein expression and function because such variations might be directly related to the development and/or progression of multiple human diseases. Indeed, the completion of the human genome project has already accelerated the identification of disease associated genetic aberrations.

KW - Cancer

KW - Drug development

KW - Gene technology

KW - Genes

KW - Genetic alterations

UR - http://www.scopus.com/inward/record.url?scp=0036276099&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036276099&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0036276099

VL - 7

SP - 16

EP - 24

JO - CME Journal of Gynecologic Oncology

JF - CME Journal of Gynecologic Oncology

SN - 1219-9087

IS - 1

ER -